EBM logo

Eastwood Bio-Medical Canada Inc. Stock Price

TSXV:EBM Community·CA$41.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

EBM Share Price Performance

CA$0.60
-0.40 (-40.00%)
CA$0.60
-0.40 (-40.00%)
Price CA$0.60

EBM Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with imperfect balance sheet.

3 Risks
1 Reward

Eastwood Bio-Medical Canada Inc. Key Details

CA$594.6k

Revenue

CA$214.6k

Cost of Revenue

CA$380.0k

Gross Profit

CA$791.8k

Other Expenses

-CA$411.8k

Earnings

Last Reported Earnings
Jul 31, 2025
Next Reporting Earnings
n/a
-0.006
63.91%
-69.27%
-4.6%
View Full Analysis

About EBM

Founded
2010
Employees
n/a
CEO
Youngsoo Kim
WebsiteView website
eleotin.ca

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. The company’s products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. is a subsidiary of Eastwood Bio-Medical Research Inc.

Recent EBM News & Updates

Recent updates

No updates